Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Appel

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cleveland Clinic Journal of Medicine|April 3, 2013
Detecting and controlling diabetic nephropathy: what do we know?Gerald Appel
Cleveland Clinic Journal of Medicine|May 18, 2007
Viral infections and the kidney: HIV, hepatitis B, and hepatitis CGerald Appel
Biomed Research International|June 18, 2016
FSGS: Diagnosis and Diagnostic Work-UpBen Sprangers, Björn Meijers, Gerald Appel
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2009
Novel B cell therapeutic targets in transplantation and immune-mediated glomerular diseasesFlavio Vincenti, Scott D Cohen, Gerald Appel
Critical Care Clinics|June 11, 2002
Thrombotic microangiopathiesDaniel Halevy, Jai Radhakrishnan, Glen Markowitz, et al.
Journal of Cutaneous Pathology|November 15, 2021
Post-COVID-19 vaccination IgA vasculitis in an adultMarc E Grossman, Gerald Appel, Alicia J Little, et al.
Clinical Nuclear Medicine|November 23, 2006
Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patientRajan Murthy, Manisha Chahal, Gerald Appel, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 2008
Rituximab treatment of fibrillary glomerulonephritisMichael Collins, Sankar D Navaneethan, Miriam Chung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Adult minimal-change disease: clinical characteristics, treatment, and outcomesMeryl Waldman, R John Crew, Anthony Valeri, et al.
Kidney International Reports|August 15, 2022
Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent ProteinuriaJonathan Barratt, James Tumlin, Yusuke Suzuki, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cleveland Clinic Journal of Medicine|April 3, 2013
Detecting and controlling diabetic nephropathy: what do we know?Gerald Appel
Cleveland Clinic Journal of Medicine|May 18, 2007
Viral infections and the kidney: HIV, hepatitis B, and hepatitis CGerald Appel
Biomed Research International|June 18, 2016
FSGS: Diagnosis and Diagnostic Work-UpBen Sprangers, Björn Meijers, Gerald Appel
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2009
Novel B cell therapeutic targets in transplantation and immune-mediated glomerular diseasesFlavio Vincenti, Scott D Cohen, Gerald Appel
Critical Care Clinics|June 11, 2002
Thrombotic microangiopathiesDaniel Halevy, Jai Radhakrishnan, Glen Markowitz, et al.
Journal of Cutaneous Pathology|November 15, 2021
Post-COVID-19 vaccination IgA vasculitis in an adultMarc E Grossman, Gerald Appel, Alicia J Little, et al.
Clinical Nuclear Medicine|November 23, 2006
Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patientRajan Murthy, Manisha Chahal, Gerald Appel, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 2008
Rituximab treatment of fibrillary glomerulonephritisMichael Collins, Sankar D Navaneethan, Miriam Chung, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 19, 2007
Adult minimal-change disease: clinical characteristics, treatment, and outcomesMeryl Waldman, R John Crew, Anthony Valeri, et al.
Kidney International Reports|August 15, 2022
Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent ProteinuriaJonathan Barratt, James Tumlin, Yusuke Suzuki, et al.
Pageof 2